PPTA Awards & Recognition

A central hub celebrating the individuals whose leadership, vision, scientific contributions, and dedication have helped advance the plasma protein therapeutics industry. Explore PPTA awards and discover the legacy of past recipients.

Recognizing Excellence Across the Plasma Protein Therapeutics Community

PPTA honors individuals whose leadership, scientific contributions, vision and dedication have helped advance the plasma protein therapeutics industry and the patients who rely on its therapies. Through its awards, PPTA recognizes those whose work, commitment and innovation have made a lasting impact on the plasma community.

Explore the awards below and celebrate the individuals whose contributions continue to shape the industry's progress.

‍

Joachim Hilfenhaus Award


The Joachim Hilfenhaus Award recognizes individuals whose contributions have significantly advanced the science, research, development, and provision of safe and effective plasma-derived medicinal products. Named in honor of Dr. Joachim Hilfenhaus, a pioneering virologist and leader in viral safety, the award celebrates individuals whose work has helped advance the field and improve outcomes for patients who rely on plasma-derived therapies.
‍

Presented annually at the International Plasma Protein Congress (IPPC), the award honors a legacy of scientific excellence, innovation, and dedication to patient care.
‍

Previous recipients:
‍

  • 2026 – Professor Noel Gerard McElvaney, Professor of Medicine, Royal College of Surgeons in Ireland
  • 2025 – Professor Isabelle Meyts
  • 2024 – Dr. Charlotte Cunningham-Rundles
  • 2023 – Dr. Thomas R. Kreil
  • 2022 – Prof. Volker Wahn
  • 2021 – Prof. Gergely Krivan
  • 2020 – Prof. Marco Circardi
  • 2019 - Prof. Isabella Quinti
  • 2018 - Prof. Mauro Bernardi
  • 2017 - Prof. Henriette Farkas
  • 2016 - Prof. Flora Peyvandi
  • 2015 - Dr. Ann Gardulf
  • 2014 - Prof. Ulrich Budde & Prof. Reinhard Schneppenheim
  • 2013 - Prof. Erik Bentorp
  • 2012 - Dr. Teresa Espanol
  • 2011 - Prof. Pier Manucci
  • 2010 - Dr. Alain Fischer
  • 2009 - Prof. Johannes Oldenburg
  • 2008 - Prof José-Luis Valverde
  • 2007 - Dr. Reinhold Schmidt
  • 2006 - Prof. Vincente Arroyo
  • 2005 - Dr. Wolfhart Kreuz
  • 2004 - Dr. Bruce Evat
  • 2003 - Dr. Helen Chapel
  • 2002 - Dr. Brackman
  • 2000 - Prof. Wolfgang Schramm
  • 1999 - Dr. Florian Horeaud
  • 1998 - Prof. Ingemar Nielsen


Dr. Otto Schwarz Award


The Dr. Otto Schwarz Award honors individuals whose leadership, dedication, and contributions have made a meaningful impact on the plasma protein therapeutics industry. Named after Dr. Otto Schwarz, a pioneer and founding leader of the plasma protein industry, the award recognizes those whose work, commitment, and vision have helped strengthen and advance the industry.
‍

PPTA presents this award to celebrate individuals whose contributions have helped shape the industry and support its continued progress.
‍

Dr. Otto Schwarz’s Legacy 

In 1992, Dr. Schwarz was one of the founders of the International Plasma Products Industry Association (IPPIA), the association representing the manufacturers of plasma protein therapies, and the forerunner of PPTA. Dr. Schwarz, along with Dr. Hans Eibl,founded Immuno AG and served as CEO of Immuno in Vienna until the company was acquired by Baxter. As one of the first Chairs of IPPIA, he recognized the importance of developing an industry view. He was the first to recognize the importance of qualified donors and how to best apply nucleic acid amplification (NAT) technology. This new technology significantly improved the ability to detect viral infections earlier than serology testing. The introduction of these steps was an early demonstration of the industry’s commitment to safety.We are pleased to recognize his legacy through the Dr. Otto Schwarz Award
‍

Previous recipients:

  • 2026 – Eduardo Herrero, Grifols
  • 2025 – Patrick Robert, Retired, Marketing Research Bureau  
  • 2024 – Rudolf E. Meixner, PlasmaVita Healthcare 
  • 2023 – Peter Turecek, Takeda
  • 2022 – Vicente Blanquer, Grifols  
  • 2021 – Jan M Bult, Consultant  
  • 2020 – Paolo Marcucci, Kedrion  
  • 2019 – Ileana Carlisle, Biotest  
  • 2018 – Shinji Wada, Grifols  
  • 2017 – Dr. Hans Peter Schwarz  
  • 2016 – Thomas R Kreil, PhD, Baxter/Shire  
  • 2015 – Dr. Herbert Dichtelmüller, Biotest 
  • 2013 – Larry Guiheen, Baxter 
  • 2012 – Dr. Steve Pettaway, Grifols 
  • 1998 – Jack Ryan 
  • 1996 – Knut Hansen 
  • ‍

Shinji Wada Visionary Award
‍

The Shinji Wada Visionary Award recognizes individuals whose vision, leadership, and commitment have helped shape the future of the plasma protein therapeutics industry. The award celebrates forward-thinking contributions, dedication to the industry's advancement, and a lasting impact on the plasma community.


Through this recognition, PPTA honors individuals whose leadership and vision inspire progress, collaboration, and continued advancement across the industry.

‍

Shinji Wada’s Legacy 

Shinji Wada served as the long-time Chairman of the PPTA Plasma Board of Directors and was a member for the Board for more than a decade. During his time as a leader in the plasma collection industry, he worked tirelessly for the advancement of the industry’s global efforts in its standards programs, donor health protection, regulatory outreach, and the importance of plasma donation for the benefit of patients. Shinji represented the entire industry in many forums around the world and always matched any industry challenge with constructive and novel solutions that benefited all. Shinji’s legacy carries on today through our industry’s efforts in these areas and many others, and is further honored through this industry award.   

‍

Previous recipients:

  • 2026 – Michael Ragusa, Haemonetics
  • 2025 – David Bell, Grifols
  • 2024 – Roger Brinser, Retired, Takeda
  • 2023 – Marilyn Rosa Bray, Grifols
  • 2022 – Martin Silver, Retired, BPL Plasma, DCI Biologicals